European-based biopharma and partner CRO employ dynamic controls of Judi for Adjudication and Site & User Qualification for rare disease immunotherapy trial with over 250 endpoints

European-based pharmaceutical company and major CRO utilize dexterity of Judi for Eligibility on pivotal phase 3, novel psychedelic clinical program

Multinational biopharmaceutical company engages innovation of Judi for Adjudication for concurrent Phase 3 clinical trials with over 900 patients, and 150 endpoints

Global biopharma sponsor selects dynamic innovation of Judi for Imaging on critical Phase 3 Oncology trial with over 170 sites and 4000 endpoints

Prominent medical device company leverages the flexibility of Judi for Imaging and Eligibility on pivotal phase 3 medical implant trial

Global Customer Value Leadership Award in the Clinical Trial Workflow Management Solutions Market